Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Targeted Therapy vs Triple Therapy in Rheumatoid Arthritis (BIO3)
NCT02714634Phase 4Recruiting
- Sponsor
- Strasbourg University Hospital
- Start
- Mar 2016
- Primary completion
- Mar 2029
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in rheumatoid arthritis (RA), sponsored by Strasbourg University Hospital. Started Mar 2016; status: recruiting.
02
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02714634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02714634.